Extrait

To investigate functional vision outcomes of intravitreal Bevacizumab (Avastin®), a recombinant humanized anti-VEGF monoclonal antibody, administered as multiple intraocular injections in patients with neovascular age-related macular degeneration compared to standard of care.

Critère d'inclusion

• Neovascular / exudative age-related macular degeneration

Liens

• ictrp
• euctr